“PRIME”: A SCHEME TO FOSTER INNOVATIVE MEDICINE

08/05/2016 1648 Views
“PRIME”: A SCHEME TO FOSTER INNOVATIVE MEDICINE

Lauched by the European Medicines Agency (EMA), PRIME will focus on the development of medicines that may improve existing treatments as well as target unmet medical needs.

Under the PRIME scheme, the EMA and medicine developers will work together since the very first stages in order to strengthen the clinical trial designs and implement the effectiveness of the results. The EMA will provide medicine developers with early, proactive and enhanced support to better research medicines’ benefits and risks. Moreover, any medicine which will be developed under PRIME will be eligible for an accelerated assessment when applying for a marketing authorisation.

Read more

Related articles